Parnes Mered, Bashir Hassaan, Jankovic Joseph
Pediatric Movement Disorders Clinic, Blue Bird Circle Clinic for Pediatric Neurology, Section of Pediatric Neurology and Developmental Neuroscience Texas Children's Hospital Houston Texas USA.
Parkinson's Disease Center and Movement Disorders Clinic, Department of Neurology Baylor College of Medicine Houston Texas USA.
Mov Disord Clin Pract. 2018 Nov 9;6(1):34-39. doi: 10.1002/mdc3.12690. eCollection 2019 Jan.
Since its localization to the gene in 2002, the phenotype of the disorder historically called "benign hereditary chorea" has been expanding beyond chorea.
The phenomenology of movement disorders and other symptomatology associated with mutations in were characterized after a detailed evaluation of consecutive patients evaluated in our clinic over the past 3 years.
We studied 5 patients (3 females), ages 2 to 31 years, with confirmed pathogenic variants in All patients exhibited chorea, gross motor delay, and gait impairment. Other symptoms included neonatal respiratory failure (n = 4), cognitive deficits (n = 3), hypothyroidism (n = 4), joint laxity (n = 2), myoclonus (n = 1), hypotonia (n = 3), and seizures (n = 1). Chorea often proved refractory to medical therapies.
The phenotype associated with pathogenic variants in frequently includes disabling and often medically refractory neurological and non-neurological abnormalities. We therefore suggest that the term benign hereditary chorea be abandoned in favor of its genetic designation as -related disorder.
自2002年该疾病定位于 基因以来,历史上称为“良性遗传性舞蹈病”的疾病表型已超出舞蹈病范畴。
在对过去3年在我们诊所连续评估的患者进行详细评估后,对与 基因突变相关的运动障碍现象学及其他症状进行了特征描述。
我们研究了5例患者(3名女性),年龄在2至31岁之间,均确诊有 基因的致病变异。所有患者均表现出舞蹈病、粗大运动发育迟缓及步态障碍。其他症状包括新生儿呼吸衰竭(n = 4)、认知缺陷(n = 3)、甲状腺功能减退(n = 4)、关节松弛(n = 2)、肌阵挛(n = 1)、肌张力减退(n = 3)及癫痫发作(n = 1)。舞蹈病通常对药物治疗无效。
与 基因致病变异相关的表型常包括致残性且通常对药物治疗无效的神经及非神经异常。因此,我们建议摒弃“良性遗传性舞蹈病”这一术语,而采用其基因命名“与 相关的疾病”。